Literature DB >> 35414843

Implications of thyroid transcription factor-1 gene methylation in carcinogenesis of interstitial pneumonia-related non-terminal respiratory unit lung adenocarcinoma.

Koji Okudela1, Takehisa Suzuki1, Toshiaki Kataoka1, Mai Matsumura1, Chihiro Koike1, Tomohisa Baba2, Hiromasa Arai3, Tae Iwasawa4, Misaki Sugiyama5, Motoki Sekiya5, Hideaki Mitsui1, Hideya Kitamura2, Tamiko Takemura5, Takashi Ogura3, Kenichi Ohashi1.   

Abstract

The present study aimed to elucidate the mechanisms underlying the histogenesis of interstitial pneumonia (IP)-related lung adenocarcinoma (LADC). We focused on the methylation of thyroid transcription factor 1 (TTF-1). The TTF-1 locus was highly methylated in IP-LADCs compared to non-IP-LADCs. Among the IP-LADCs, the non-terminal respiratory unit (TRU) LADCs showed marked hypermethylation in CpG sites in a particular intragenic region. This region was also found to be highly methylated in the IP lungs. The hierarchical dendrogram based on methylation levels divided the IP lungs into three different clusters. One of them showed a methylation profile similar to that of non-TRU LADCs. The non-TRU LADCs developed from this cluster with a significantly higher frequency. Moreover, bronchiolar metaplasia lining honeycomb/cystic lesions in IP lungs, IP-related non-TRU LADCs, and bronchiolar epithelia in healthy lungs were separately collected by microdissection and examined for methylation. Bronchiolar metaplasia showed hypermethylation, but bronchiolar epithelia did not. The methylation patterns in bronchiolar metaplasia were similar to those in non-TRU LADCs. In summary, a particular region of TTF-1 was highly methylated in IP-related non-TRU LADCs and bronchiolar metaplasia, supporting the theory that IP-related non-TRU LADCs may develop from bronchiolar metaplasia lining honeycomb/cystic lesions. IJCEP
Copyright © 2022.

Entities:  

Keywords:  Non-TRU lung adenocarcinoma; TTF-1 methylation; bronchiolar metaplasia; interstitial pneumonia

Year:  2022        PMID: 35414843      PMCID: PMC8986470     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  Cumulative incidence of and predictive factors for lung cancer in IPF.

Authors:  Yuichi Ozawa; Takafumi Suda; Tateaki Naito; Noriyuki Enomoto; Dai Hashimoto; Tomoyuki Fujisawa; Yutaro Nakamura; Naoki Inui; Hirotoshi Nakamura; Kingo Chida
Journal:  Respirology       Date:  2009-07       Impact factor: 6.424

2.  The predominant expression of hepatocyte nuclear factor 4α (HNF4α) in thyroid transcription factor-1 (TTF-1)-negative pulmonary adenocarcinoma.

Authors:  Ryosuke Kunii; Shuying Jiang; Go Hasegawa; Takashi Yamamoto; Hajime Umezu; Takehiro Watanabe; Masanori Tsuchida; Takehisa Hashimoto; Takao Hamakubo; Tatsuhiko Kodama; Keisuke Sasai; Makoto Naito
Journal:  Histopathology       Date:  2011-02-23       Impact factor: 5.087

3.  A subpopulation of airway epithelial cells that express hepatocyte nuclear factor 4α - its implication in the development of non-terminal respiratory unit-type lung adenocarcinoma.

Authors:  Koji Okudela; Hiromasa Arai; Hideya Kitamura; Tomohisa Baba; Hideaki Mitsui; Takehisa Suzuki; Misaki Sugiyama; Emi Honda; Mai Matsumura; Tamiko Takemura; Toshiaki Kataoka; Chihiro Koike; Yoko Tateshi; Michihiko Tajiri; Takashi Ogura; Kenichi Ohashi
Journal:  Histol Histopathol       Date:  2019-03-08       Impact factor: 2.303

4.  Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma.

Authors:  Daichi Fujimoto; Keisuke Tomii; Takehiro Otoshi; Takahisa Kawamura; Koji Tamai; Junpei Takeshita; Kosuke Tanaka; Takeshi Matsumoto; Kazuya Monden; Kazuma Nagata; Kyoko Otsuka; Atsushi Nakagawa; Akito Hata; Ryo Tachikawa; Kojiro Otsuka; Hiroshi Hamakawa; Nobuyuki Katakami; Yutaka Takahashi; Yukihiro Imai
Journal:  Lung Cancer       Date:  2013-02-16       Impact factor: 5.705

5.  Hh pathway expression in human gut tissues and in inflammatory gut diseases.

Authors:  Corinne M Nielsen; Jerrell Williams; Gijs R van den Brink; Gregory Y Lauwers; Drucilla J Roberts
Journal:  Lab Invest       Date:  2004-12       Impact factor: 5.662

Review 6.  Association of malignancy with diseases causing interstitial pulmonary changes.

Authors:  Demosthenes Bouros; Kostas Hatzakis; Haris Labrakis; Kyriaki Zeibecoglou
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

7.  Lung cancer associated with usual interstitial pneumonia.

Authors:  H Matsushita; S Tanaka; Y Saiki; M Hara; K Nakata; S Tanimura; J Banba
Journal:  Pathol Int       Date:  1995-12       Impact factor: 2.534

8.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

9.  Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.

Authors:  Eric L Snyder; Hideo Watanabe; Margaret Magendantz; Sebastian Hoersch; Tiffany A Chen; Diana G Wang; Denise Crowley; Charles A Whittaker; Matthew Meyerson; Shioko Kimura; Tyler Jacks
Journal:  Mol Cell       Date:  2013-03-21       Impact factor: 17.970

10.  Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.

Authors:  Daisuke Matsubara; Manabu Soda; Taichiro Yoshimoto; Yusuke Amano; Yuji Sakuma; Azusa Yamato; Toshihide Ueno; Shinya Kojima; Tomoki Shibano; Yasuyuki Hosono; Masahito Kawazu; Yoshihiro Yamashita; Shunsuke Endo; Koichi Hagiwara; Masashi Fukayama; Takashi Takahashi; Hiroyuki Mano; Toshiro Niki
Journal:  Cancer Sci       Date:  2017-07-29       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.